DC Field | Value | Language |
---|---|---|
dc.contributor.author | H M Li | - |
dc.contributor.author | Jae Kyung Lee | - |
dc.contributor.author | L J Nie | - |
dc.contributor.author | Q Huo | - |
dc.contributor.author | T Ma | - |
dc.contributor.author | J K Sohng | - |
dc.contributor.author | Young-Soo Hong | - |
dc.contributor.author | C Z Wu | - |
dc.date.accessioned | 2017-04-19T10:15:32Z | - |
dc.date.available | 2017-04-19T10:15:32Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | 10.1007/s12272-015-0658-8 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/13042 | - |
dc.description.abstract | Glycosylation is often used to improve a natural product's properties such as water solubility, chemical stability, pharmacological potency, and structure diversification. In this study, we studied the enzymatic synthesis of novel isobavachalcone glucosides using a UDP-glycosyltransferase (YjiC) from Bacillus licheniformis DSM-13. The chemical structures of compounds 1 and 2 were elucidated by spectroscopic techniques, including LC-MS, MS, and NMR. Meanwhile, the parameters of glycosylation reaction such as incubation time, UDP-glucose concentration, and pH of buffer were also optimized during this study. Furthermore, the compounds 1 and 2 exhibited weak anti-proliferative activities against five human cancer cell lines, with IC50 values ranging from 58.6 to 86.6 μM. | - |
dc.publisher | Pharmaceutical Soc Korea | - |
dc.title | Enzymatic synthesis of novel isobavachalcone glucosides via a UDP-glycosyltransferase | - |
dc.title.alternative | Enzymatic synthesis of novel isobavachalcone glucosides via a UDP-glycosyltransferase | - |
dc.type | Article | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.number | 12 | - |
dc.citation.endPage | 2215 | - |
dc.citation.startPage | 2208 | - |
dc.citation.volume | 38 | - |
dc.contributor.affiliatedAuthor | Jae Kyung Lee | - |
dc.contributor.affiliatedAuthor | Young-Soo Hong | - |
dc.contributor.alternativeName | Li | - |
dc.contributor.alternativeName | 이재경 | - |
dc.contributor.alternativeName | Nie | - |
dc.contributor.alternativeName | Huo | - |
dc.contributor.alternativeName | Ma | - |
dc.contributor.alternativeName | 송재경 | - |
dc.contributor.alternativeName | 홍영수 | - |
dc.contributor.alternativeName | Wu | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, vol. 38, no. 12, pp. 2208-2215 | - |
dc.identifier.doi | 10.1007/s12272-015-0658-8 | - |
dc.subject.keyword | Cytotoxicity | - |
dc.subject.keyword | Diversification | - |
dc.subject.keyword | Glycosylation | - |
dc.subject.keyword | Isobavachalcone | - |
dc.subject.keyword | YjiC | - |
dc.subject.local | Cytotoxicity | - |
dc.subject.local | cytotoxicity | - |
dc.subject.local | Diversification | - |
dc.subject.local | glycosylation | - |
dc.subject.local | Glycosylation | - |
dc.subject.local | Isobavachalcone | - |
dc.subject.local | YjiC | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.